Structure-to-Efficacy Relationship of HPMA-Based Nanomedicines: The Tumor Spheroid Penetration Study
- Supplementary File 1:
PDF-Document (PDF, 152 KiB)
Kudláčová, J.; Kotrchová, L.; Kostka, L.; Randárová, E.; Filipová, M.; Janoušková, O.; Fang, J.; Etrych, T. Structure-to-Efficacy Relationship of HPMA-Based Nanomedicines: The Tumor Spheroid Penetration Study. Pharmaceutics 2020, 12, 1242. https://doi.org/10.3390/pharmaceutics12121242
Kudláčová J, Kotrchová L, Kostka L, Randárová E, Filipová M, Janoušková O, Fang J, Etrych T. Structure-to-Efficacy Relationship of HPMA-Based Nanomedicines: The Tumor Spheroid Penetration Study. Pharmaceutics. 2020; 12(12):1242. https://doi.org/10.3390/pharmaceutics12121242
Chicago/Turabian StyleKudláčová, Júlia, Lenka Kotrchová, Libor Kostka, Eva Randárová, Marcela Filipová, Olga Janoušková, Jun Fang, and Tomáš Etrych. 2020. "Structure-to-Efficacy Relationship of HPMA-Based Nanomedicines: The Tumor Spheroid Penetration Study" Pharmaceutics 12, no. 12: 1242. https://doi.org/10.3390/pharmaceutics12121242